Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EVELYN S ACKERMANN

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1053308676
CMS profile
274926
Location
ELGIN, IL

General Payments · PY2018–2024

$2,669.65

  • Reported across 101 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$321.84

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $321.84 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Bausch & Lomb Americas Inc. $108.58 5
Oyster Point Pharma, Inc. $73.08 3
Harrow Eye, LLC $56.70 2
ABBVIE INC. $25.84 1
Thea Pharma Inc. $24.73 1
Tarsus Pharmaceuticals, Inc. $18.21 1
Astellas Pharma US Inc $14.70 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $648.88 22
PY2019 $306.75 13
PY2020 $58.02 3
PY2021 $187.77 11
PY2022 $880.12 25
PY2023 $266.27 13
PY2024 $321.84 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.84 09/30/2024 Food and Beverage Undisputed 01/23/2026 1103171980 CMS
Astellas Pharma US Inc $14.70 08/16/2024 Food and Beverage Undisputed 01/23/2026 1139424929 CMS
Bausch & Lomb Americas Inc. $21.37 04/02/2024 Food and Beverage Undisputed 01/23/2026 1140344222 CMS
Bausch & Lomb Americas Inc. $20.94 06/24/2024 Food and Beverage Undisputed 01/23/2026 1140344224 CMS
Bausch & Lomb Americas Inc. $22.78 08/27/2024 Food and Beverage Undisputed 01/23/2026 1140344226 CMS
Bausch & Lomb Americas Inc. $22.10 10/21/2024 Food and Beverage Undisputed 01/23/2026 1140344230 CMS
Bausch & Lomb Americas Inc. $21.39 11/06/2024 Food and Beverage Undisputed 01/23/2026 1140344228 CMS
Harrow Eye, LLC $28.76 04/18/2024 Food and Beverage Undisputed 01/23/2026 1145596410 CMS
Harrow Eye, LLC $27.94 06/28/2024 Food and Beverage Undisputed 01/23/2026 1145596412 CMS
Oyster Point Pharma, Inc. $24.31 04/25/2024 Food and Beverage Undisputed 01/23/2026 1147403938 CMS
Oyster Point Pharma, Inc. $25.41 07/18/2024 Food and Beverage Undisputed 01/23/2026 1147406702 CMS
Oyster Point Pharma, Inc. $23.36 10/31/2024 Food and Beverage Undisputed 01/23/2026 1147411369 CMS
Tarsus Pharmaceuticals, Inc. $18.21 02/16/2024 Food and Beverage Undisputed 01/23/2026 1139078049 CMS
Thea Pharma Inc. $24.73 10/10/2024 Food and Beverage Undisputed 01/23/2026 1074538951 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.